romilkimab
mAbexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Interleukin-13ANTAGONIST
IL13
- Interleukin-4ANTAGONIST
IL4
- Interleukin-4INHIBITOR
Interleukin-4 inhibitor
- Interleukin-13INHIBITOR
Interleukin-13 inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4298097 ↗